| Transcriptional activity (% activity of SV40 T antigen) | ||
---|---|---|---|
Cells | MK | Sur | COX-2 |
Pancreatic carcinoma | |||
 AsPC-1 | 345 ± 59.9 | 75.6 ± 2.9 | 212 ± 11.5 |
 PANC-1 | 224 ± 3.6 | 69.8 ± 4.28 | 243 ± 11.4 |
 BxPC-3 | 454 ± 49.1 | 67.8 ± 10.6 | 363 ± 86.5 |
 MIA-PaCa-2 | 182 ± 22.4 | 135 ± 7.0 | 783 ± 27.6 |
Esophageal carcinoma | |||
 TE-1 | 400 ± 99.0 | 162 ± 13.6 | 752 ± 71.9 |
 TE-2 | 375 ± 7.9 | 610 ± 136.5 | 625 ± 28.1 |
 TE-10 | 339 ± 26.9 | 906 ± 34.9 | 431 ± 59.5 |
 TE-11 | 702 ± 30.2 | 6770 ± 526.0 | 410 ± 128.0 |
 YES-2 | 314 ± 20.2 | 1790 ± 156.0 | 351 ± 27.1 |
 YES-4 | 187 ± 2.6 | 310 ± 13.2 | 282 ± 18.5 |
 YES-5 | 745 ± 47.7 | 395 ± 11.2 | 160 ± 12.5 |
 YES-6 | 540 ± 7.4 | 3110 ± 96.8 | 417 ± 31.4 |
 T.Tn | 199 ± 32.0 | 2410 ± 233.0 | 126 ± 10.2 |
Mesothelioma | |||
 NCI-H2452 | 153 ± 45.7 | 35.0 ± 5.0 | 291 ± 72.4 |
 NCI-H2052 | 189 ± 4.5 | 38.6 ± 1.0 | 233 ± 10.1 |
 NCI-H226 | 112 ± 4.2 | 7.2 ± 0.3 | 381 ± 61.2 |
 NCI-H28 | 348 ± 68.2 | 173 ± 62.1 | 250 ± 38.2 |
 MSTO-211H | 168 ± 18.4 | 134 ± 7.3 | 141 ± 14.0 |